• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡型甲状腺乳头状癌淋巴结转移的预测因素。

Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma.

机构信息

Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Ann Surg Oncol. 2017 Sep;24(9):2617-2623. doi: 10.1245/s10434-017-5912-5. Epub 2017 Jul 6.

DOI:10.1245/s10434-017-5912-5
PMID:28685355
Abstract

BACKGROUND

Compared with conventional papillary thyroid carcinoma (PTC), follicular variant of PTC (FV-PTC) shows less aggressive behavior and better prognosis. Nonetheless, regional lymph node (LN) metastasis was found in 22.8% of FV-PTC patients. Because LN metastasis is a proven predictor of recurrence in PTC, it is important to assess LN metastasis in FV-PTC patients.

METHODS

We retrospectively reviewed 134 FV-PTC patients who underwent thyroidectomy with neck dissection.

RESULTS

Central LN metastasis (CLNM) and lateral LN metastasis (LLNM) were found in 50 (37.3%) and 16 (11.9%) patients, respectively. In the multivariate analysis for CLNM, male sex (adjusted OR 4.735, p = 0.001), nonencapsulated form (adjusted OR 2.863, p = 0.022), and tumor size >1.0 cm (adjusted OR 3.157, p = 0.008) were independent predictors of high prevalence of CLNM in FV-PTC patients. In the multivariate analysis for LLNM, microscopic extrathyroidal extension (ETE) (adjusted OR 3.939, p = 0.041) and CLNM (adjusted OR 13.340, p = 0.001) were independent predictors of high prevalence of LLNM in FV-PTC patients.

CONCLUSIONS

Meticulous perioperative evaluation and prophylactic central neck dissection may be beneficial for FV-PTC patients with male sex, nonencapsulated form, and tumor size >1.0 cm. Moreover, cautious perioperative evaluation of lateral neck LN may be mandatory for FV-PTC patients with microscopic ETE and CLNM.

摘要

背景

与传统的甲状腺乳头状癌(PTC)相比,滤泡型 PTC(FV-PTC)表现出侵袭性较弱和预后较好的特点。然而,仍有 22.8%的 FV-PTC 患者存在区域淋巴结(LN)转移。由于 LN 转移是 PTC 复发的一个明确预测因素,因此评估 FV-PTC 患者的 LN 转移情况非常重要。

方法

我们回顾性分析了 134 例接受甲状腺切除术和颈部淋巴结清扫术的 FV-PTC 患者。

结果

50 例(37.3%)和 16 例(11.9%)患者分别发现中央淋巴结转移(CLNM)和侧方淋巴结转移(LLNM)。CLNM 的多因素分析显示,男性(调整后的 OR 4.735,p=0.001)、非包膜型(调整后的 OR 2.863,p=0.022)和肿瘤直径>1.0cm(调整后的 OR 3.157,p=0.008)是 FV-PTC 患者 CLNM 发生率高的独立预测因素。LLNM 的多因素分析显示,显微镜下甲状腺外侵犯(ETE)(调整后的 OR 3.939,p=0.041)和 CLNM(调整后的 OR 13.340,p=0.001)是 FV-PTC 患者 LLNM 发生率高的独立预测因素。

结论

对于男性、非包膜型和肿瘤直径>1.0cm 的 FV-PTC 患者,应进行仔细的围手术期评估和预防性中央颈部淋巴结清扫术。此外,对于显微镜下甲状腺外侵犯和 CLNM 的 FV-PTC 患者,应谨慎进行侧颈部 LN 的围手术期评估。

相似文献

1
Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma.滤泡型甲状腺乳头状癌淋巴结转移的预测因素。
Ann Surg Oncol. 2017 Sep;24(9):2617-2623. doi: 10.1245/s10434-017-5912-5. Epub 2017 Jul 6.
2
Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌淋巴结转移的预测因素
Ann Surg Oncol. 2016 Sep;23(9):2866-73. doi: 10.1245/s10434-016-5225-0. Epub 2016 Apr 13.
3
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
4
Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.分析预测甲状腺乳头状癌颈淋巴结转移的风险因素:966 例患者研究。
BMC Cancer. 2019 Jun 25;19(1):622. doi: 10.1186/s12885-019-5835-6.
5
Patterns, Predictive Factors, and Prognostic Impact of Contralateral Lateral Lymph Node Metastasis in N1b Papillary Thyroid Carcinoma.N1b 期乳头状甲状腺癌对侧颈部淋巴结转移的模式、预测因素及预后影响
Ann Surg Oncol. 2017 Jul;24(7):1943-1950. doi: 10.1245/s10434-016-5761-7. Epub 2017 Feb 3.
6
Significance of multifocality in papillary thyroid carcinoma.多灶性在甲状腺乳头状癌中的意义。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
7
Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.单侧甲状腺乳头状癌对侧气管旁淋巴结转移的预测因素
Eur J Surg Oncol. 2015 Jun;41(6):746-50. doi: 10.1016/j.ejso.2015.02.013. Epub 2015 Apr 2.
8
Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.高位甲状腺微小乳头状癌是侧颈部淋巴结转移的危险因素。
Ann Surg Oncol. 2019 Nov;26(12):3992-4001. doi: 10.1245/s10434-019-07587-2. Epub 2019 Jul 1.
9
Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.甲状腺乳头状癌的隐匿性转移在临床实践中难以预测。
BMC Cancer. 2017 Oct 25;17(1):702. doi: 10.1186/s12885-017-3698-2.
10
High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).单侧乳头状甲状腺癌(cT1N0)对侧中央区淋巴结转移的高危因素。
Eur J Surg Oncol. 2021 Apr;47(4):882-887. doi: 10.1016/j.ejso.2020.10.018. Epub 2020 Oct 18.

引用本文的文献

1
Retinoid X receptor γ regulates epithelial-mesenchymal transition and tumor immune infiltration in papillary thyroid cancer tumorigenesis: an experimental and in silico study.维甲酸X受体γ在甲状腺乳头状癌肿瘤发生过程中调节上皮-间质转化和肿瘤免疫浸润:一项实验和计算机模拟研究
Endocr Connect. 2025 Jun 17;14(6). doi: 10.1530/EC-25-0015. Print 2025 Jun 1.
2
Establishing a Novel Pyroptosis-Related Gene Signature and Predicting Chemical Drugs for Papillary Thyroid Cancer.建立一种新型的焦亡相关基因特征并预测甲状腺乳头状癌的化学药物。
Curr Pharm Biotechnol. 2024 Nov 1. doi: 10.2174/0113892010325685241029113633.
3
Prevalence of Occult Central Lymph Node Metastasis by Tumor Size in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
甲状腺乳头状癌中隐匿性中央区淋巴结转移与肿瘤大小的相关性:一项系统评价和荟萃分析。
Curr Oncol. 2023 Aug 2;30(8):7335-7350. doi: 10.3390/curroncol30080532.
4
Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer.甲状腺癌焦亡相关预后标志物的鉴定与验证
Cancer Cell Int. 2021 Oct 9;21(1):523. doi: 10.1186/s12935-021-02231-0.
5
Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis.通过qRT-PCR、TCGA和计算机分析对甲状腺乳头状癌中CDH16的下调及其潜在分子机制进行分析
Cancer Manag Res. 2019 Dec 23;11:10719-10729. doi: 10.2147/CMAR.S229631. eCollection 2019.
6
Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.生长相关蛋白 43 通过上皮-间充质转化促进甲状腺癌细胞系的进展。
J Cell Mol Med. 2019 Dec;23(12):7974-7984. doi: 10.1111/jcmm.14460. Epub 2019 Sep 30.
7
Expression of ANGPTL2 and its impact on papillary thyroid cancer.血管生成素样蛋白2(ANGPTL2)的表达及其对甲状腺乳头状癌的影响。
Cancer Cell Int. 2019 Jul 30;19:204. doi: 10.1186/s12935-019-0908-9. eCollection 2019.
8
Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma.INPPL1的低表达与甲状腺乳头状癌的侵袭性临床病理特征相关。
Onco Targets Ther. 2018 Nov 1;11:7725-7731. doi: 10.2147/OTT.S185803. eCollection 2018.
9
A novel tumor suppressor gene is correlated with progression in papillary thyroid carcinoma.一种新型肿瘤抑制基因与甲状腺乳头状癌的进展相关。
Onco Targets Ther. 2018 Jan 11;11:307-311. doi: 10.2147/OTT.S154158. eCollection 2018.